Dean Investment Associates, LLC Bristol Myers Squibb CO Transaction History

Dean Investment Associates, LLC

$726 Million
Q3 2024

A detailed history of Dean Investment Associates, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dean Investment Associates, LLC holds 78,796 shares of BMY stock, worth $4.55 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

78,796

Previous 84,295 6.52%

Holding current value

$4.55 Million

Previous $3.5 Million 16.49%

% of portfolio

0.56%

Previous 0.5%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$39.66 - $51.75 $218,090 - $284,573	-5,499 Reduced 6.52%	78,796 $4.08 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $125,419 - $165,116	-3,116 Reduced 3.56%	84,295 $3.5 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $798,771 - $905,651	16,648 Added 23.53%	87,411 $4.74 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $726,569 - $866,997	-14,987 Reduced 17.48%	70,763 $3.63 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $49,206 - $55,020	850 Added 1.0%	85,750 $4.98 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $1.13 Million - $1.26 Million	17,777 Added 26.48%	84,900 $5.43 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $349,182 - $396,052	5,314 Added 8.6%	67,123 $4.65 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $479,496 - $567,792	7,002 Added 12.78%	61,809 $4.45 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $94 - $55,862	727 Added 1.34%	54,807 $3.9 Million
Q2 2022 Aug 18, 2022	SELL	$72.62 - $79.98 $1.63 Million - $1.8 Million	-22,493 Reduced 29.37%	54,080 $4.16 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $67,136 - $80,502	1,092 Added 1.45%	76,573 $5.59 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $134,933 - $157,300	-2,516 Reduced 3.23%	75,481 $4.71 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $36,093 - $42,279	-610 Reduced 0.78%	77,997 $4.62 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $7,491 - $8,157	-121 Reduced 0.15%	78,607 $5.25 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $44,208 - $49,721	-745 Reduced 0.94%	78,728 $4.97 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $199,549 - $226,126	-3,456 Reduced 4.17%	79,473 $4.93 Million
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $88,212 - $97,751	-1,536 Reduced 1.82%	82,929 $5 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $25,710 - $30,058	-469 Reduced 0.55%	84,465 $4.97 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $25,844 - $37,558	-557 Reduced 0.65%	84,934 $4.73 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $1.41 Million - $1.84 Million	-28,680 Reduced 25.12%	85,491 $5.49 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $43,882 - $52,028	1,026 Added 0.91%	114,171 $5.79 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $3.18 Million - $3.52 Million	71,342 Added 170.66%	113,145 $5.13 Million
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $1.89 Million - $2.25 Million	41,803 New	41,803 $1.99 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Investment Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dean Investment Associates, LLC with notifications on news.

Account

Dean Investment Associates, LLC Bristol Myers Squibb CO Transaction History